医院内鲍曼不动杆菌感染分布与耐药性分析
Analysis on Infection Distribution and Drug Resistance of Acinetobacter Baumanni in Hospital
史庭明 1李余莎1
作者信息
- 1. 郴州市中医医院检验科 湖南郴州 423000
- 折叠
摘要
目的：分析了解临床标本分离培养鲍曼不动杆菌的分布及耐药性特点。方法收集我院2012年3月至2014年3月期间的临床标本，使用VITEK 2全自动细菌鉴定药敏分析仪进行细菌学鉴定和药敏试验。结果在126株鲍曼不动杆菌中，大部分(76.2％)是从痰液标本中分离得到，重症监护病房分布占了主要部分(40.5％)。临床常用治疗药物中，鲍曼不动杆菌对米诺环素与头孢哌酮／舒巴坦的敏感性较好(＞90％)，其它临床常用药物的敏感性均较差(＜50％)。结论鲍曼不动杆菌多层耐药现象严重，应加强耐药性监测，减少及防止鲍曼不动杆菌引起的医院内感染。
Abstract
Objective: To study the distribution and drug resistance of Acinetobacter Baumanni by clinical sample isolation and culture. Methods: Colected clinical samples in this hospital from March 2012 to March 2014 and took the identification of bacteria and drug sensitivity test by VITEK2 automatic bacteria assay drug sensitive analyzer. Results: Among 126 strains of Acinetobacter Baumanni, most of them (76.2%) were isolated from sputu m sample, while the distribution in intensive care unit occupied the major part (40.5%). For clinical common drugs, Acinetobacter Baumanni had a good sensitivity to minocy cline and cefoperazone/sulbactam (>90%), but a poor sensitivity to other clinical common drugs (<50%). Conclusion: The multiple drug resistance of Acinetobacter Baumann-i is severe and it should enhance the supervision on drug resistance to reduce and avoid the in-hospital infection induced by Acinetobacter Baumanni.
关键词
鲍曼不动杆菌/耐药性/抗菌药物Key words
Acinetobacter Baumanni/Drug Resistance/Antimicrobial Agent引用本文复制引用
出版年
2014
NETL
NSTL
万方数据